(ASRNL) ASR Nederland - AS

Sector: Financial Services | Industry: Insurance - Diversified | Exchange: AS (Netherlands) | Market Cap: 13.063m EUR | Total Return: 19.8% in 12m

Insurance, Pensions, Mortgages, Asset Management
Total Rating 36
Safety 18
Buy Signal -1.06
Insurance - Diversified
Industry Rotation: -1.6
Market Cap: 15.1B
Avg Turnover: 29.3M
Risk 3d forecast
Volatility16.9%
VaR 5th Pctl2.97%
VaR vs Median6.52%
Reward TTM
Sharpe Ratio1.14
Rel. Str. IBD62.6
Rel. Str. Peer Group83.3
Character TTM
Beta0.255
Beta Downside-0.020
Hurst Exponent0.502
Drawdowns 3y
Max DD19.40%
CAGR/Max DD1.18
CAGR/Mean DD6.34

Warnings

Fakeout

Tailwinds

No distinct edge detected

Description: ASRNL ASR Nederland

ASR Nederland N.V. is a Dutch financial services provider specializing in insurance, pensions, and mortgages. The company operates across five primary segments: Non-Life, Life, Asset Management, Distribution and Services, and Holding and Other. Its portfolio includes disability, property and casualty, health, and funeral insurance, alongside pension products and individual term life policies.

The business model relies on a multi-brand strategy, utilizing names such as a.s.r. and Aegon to penetrate the residential mortgage market. As a multi-line insurer, ASR Nederland benefits from diversified revenue streams, balancing the shorter-term underwriting cycles of non-life products with the long-term capital management requirements of life and pension segments. The company also manages an extensive real estate and renewable energy asset portfolio, including wind and solar farms.

Historical data and valuation metrics on ValueRay can help clarify how these segments contribute to long-term growth. Founded in 1720 and headquartered in Utrecht, the firm maintains a significant presence in the Dutch domestic market through both direct services and specialized advisory brands focused on occupational health and reintegration.

Headlines to Watch Out For
  • Integration of Aegon Netherlands assets accelerates cost synergies and market share growth
  • Solvency II ratio fluctuations impact capital return and dividend payout sustainability
  • Dutch mortgage market volatility influences asset management fees and interest margins
  • Regulatory shifts in pension reform affect long-term life insurance liability management
  • Rising claims inflation in non-life segments pressures technical margins and pricing power
Piotroski VR-10 (Strict) 3.0
Net Income: 583.0m TTM > 0 and > 6% of Revenue
FCF/TA: -0.00 > 0.02 and ΔFCF/TA 0.11 > 1.0
NWC/Revenue: -70.55% < 20% (prev 51.29%; Δ -121.8% < -1%)
CFO/TA -0.00 > 3% & CFO -569.0m > Net Income 583.0m
Net Debt (7.83b) to EBITDA (8.18b): 0.96 < 3
Current Ratio: 0.19 > 1.5 & < 3
Outstanding Shares: last quarter (207.5m) vs 12m ago -11.93% < -2%
Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin)
Asset Turnover: 13.19% > 50% (prev 8.37%; Δ 4.83% > 0%)
Interest Coverage Ratio: 1.33 > 6 (EBIT TTM 8.03b / Interest Expense TTM 6.03b)
Altman Z'' -0.05
A: -0.09 (Total Current Assets 3.06b - Total Current Liabilities 16.1b) / Total Assets 142b
B: 0.03 (Retained Earnings 4.34b / Total Assets 142b)
C: 0.06 (EBIT TTM 8.03b / Avg Total Assets 140b)
D: 0.06 (Book Value of Equity 8.60b / Total Liabilities 134b)
Altman-Z'' = -0.05 = B
Beneish M -1.28
DSRI: 3.0 (Receivables 351.0m/72.0m, Revenue 18.5b/11.6b)
GMI: 0.59 (GM 59.28% / 100.0%)
AQI: 1.07 (AQ_t 0.97 / AQ_t-1 0.91)
SGI: 1.60 (Revenue 18.5b / 11.6b)
TATA: 0.01 (NI 583.0m - CFO -569.0m) / TA 142b)
Beneish M = -1.28 (Cap -4..+1) = D
What is the price of ASRNL shares?

As of June 10, 2026, the stock is trading at EUR 63.60 with a total of 424,355 shares traded.
Over the past week, the price has changed by +0.25%, over one month by -0.85%, over three months by +14.49% and over the past year by +19.79%.

Is ASRNL a buy, sell or hold?

ASR Nederland has no consensus analysts rating.

ASR Nederland (ASRNL) - Fundamental Data Overview as of 08 June 2026
Market Cap USD = 15.1b (13.1b EUR * 1.1522 EUR.USD)
P/E Trailing = 29.2685
P/E Forward = 10.5708
P/S = 0.7628
P/B = 1.2746
Revenue TTM = 18.5b EUR
EBIT TTM = 8.03b EUR
EBITDA TTM = 8.18b EUR
Long Term Debt = 8.91b EUR (from longTermDebt, last quarter)
Short Term Debt = 70.0m EUR (from shortTermDebt, last fiscal year)
Debt = 10.5b EUR (from shortLongTermDebtTotal, last quarter) + Leases 120.0m
Net Debt = 7.83b EUR (calculated: Debt 10.5b - CCE 2.71b)
Enterprise Value = 20.9b EUR (13.1b + Debt 10.5b - CCE 2.71b)
Interest Coverage Ratio = 1.33 (Ebit TTM 8.03b / Interest Expense TTM 6.03b)
EV/FCF = -35.60x (Enterprise Value 20.9b / FCF TTM -587.0m)
FCF Yield = -2.81% (FCF TTM -587.0m / Enterprise Value 20.9b)
FCF Margin = -3.17% (FCF TTM -587.0m / Revenue TTM 18.5b)
Net Margin = 3.15% (Net Income TTM 583.0m / Revenue TTM 18.5b)
 Gross Margin = unknown ((Revenue TTM 18.5b - Cost of Revenue TTM 0.0) / Revenue TTM)
 Tobins Q-Ratio = 0.15 (Enterprise Value 20.9b / Total Assets 142b)
 Interest Expense / Debt = 57.20% (Interest Expense 6.03b / Debt 10.5b)
 Taxrate = 18.79% (131.0m / 697.0m)
NOPAT = 6.52b (EBIT 8.03b * (1 - 18.79%))
Current Ratio = 0.19 (Total Current Assets 3.06b / Total Current Liabilities 16.1b)
Debt / Equity = 1.23 (Debt 10.5b / totalStockholderEquity, last quarter 8.60b)
Debt / EBITDA = 0.96 (Net Debt 7.83b / EBITDA 8.18b)
 Debt / FCF = -13.34 (negative FCF - burning cash) (Net Debt 7.83b / FCF TTM -587.0m)
 Total Stockholder Equity = 9.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.42% (Net Income 583.0m / Total Assets 142b)
RoE = 6.22% (Net Income TTM 583.0m / Total Stockholder Equity 9.37b)
RoCE = 43.91% (EBIT 8.03b / Capital Employed (Equity 9.37b + L.T.Debt 8.91b))
RoIC = 5.21% (NOPAT 6.52b / Invested Capital 125b)
WACC = 3.81% (E(13.1b)/V(23.6b) * Re(6.88%) + (debt cost/tax rate unavailable))
Discount Rate = 6.88% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 46.00 | Cagr: 19.53%
 [DCF] Fair Price = unknown (Cash Flow -587.0m)
 EPS Correlation: -60.73 | EPS CAGR: -24.20% | SUE: N/A | # QB: 0
Revenue Correlation: 91.10 | Revenue CAGR: 29.92% | SUE: 0.88 | # QB: 1
EPS current Year (2026-12-31): EPS=6.09 | Chg30d=+0.00% | Revisions=-20% | GrowthEPS=-4.2% | GrowthRev=+18.7%
EPS next Year (2027-12-31): EPS=6.24 | Chg30d=+0.00% | Revisions=+20% | GrowthEPS=+2.6% | GrowthRev=-7.3%
[Analyst] Revisions Ratio: -20%